Form 4 for LONA LeonaBio, Inc.
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-12 · accession 0001209191-22-024219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-12 | 2022-04-11 | LONA | MILESON GLENNA | CFO | M - OptEx | $10.64 | +3,000 | 100.1K | +3% | +$31.9K |
| D | 2022-04-12 | 2022-04-11 | LONA | MILESON GLENNA | CFO | M - OptEx | $0.00 | -3,000 | 167.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-11 | M | A | 3,000 | $10.64 | 100,060 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-04-11 | M | D | 3,000 | $0.00 | 167,000 | D | $10.64 · — to 2032-01-17 | 3,000 Common Stock | (F1) One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter. |